Skip to main content

Table 4 Other outcomes

From: Surgical site infections following colorectal cancer surgery: a randomized prospective trial comparing common and advanced antimicrobial dressing containing ionic silver

Characteristic

 

A

B

Overall

P a

  

N (%)

N (%)

  

Necrosis

Fair

0

2 (3.5)

2 (1.8)

 
 

Light

1 (1.9)

0

1 (0.9)

0.361

 

None

53 (98.1)

56 (96.5)

109 (97.3)

 

Erythema

Fair

2 (3.7)

0

2 (1.8)

 
 

Light

4 (7.4)

9 (15.5)

13 (11.6)

0.158

 

None

48 (88.9)

49 (84.5)

97 (86.6)

 

Edema

Light

5 (9.3)

3 (5.2)

8 (7.1)

0.479

 

None

49 (90.7)

55 (94.8)

104 (92.9)

 

Hematoma

No

51 (94.4)

53 (91.4)

104 (92.9)

0.718

 

Yes

3 (5.6)

5 (8.6)

8 (7.1)

 

Fever

No

47 (87.0)

47 (81.0)

94 (83.9)

0.447

 

Yes

7 (13.0)

11 (19.0)

18 (16.1)

 

Shiver

No

51 (94.4)

55 (94.8)

106 (94.6)

1.000

 

Yes

3 (5.6)

3 (5.2)

6 (5.4)

 

Leukocytosis

No

45 (83.3)

48 (82.8)

93 (83.0)

1.000

 

Yes

9 (16.7)

10 (17.2)

19 (17.0)

 

Infection within 30 days

No

46 (85.2)

52 (89.7)

98 (87.5)

0.572

 

Yes

8 (14.8)

6 (10.3)

14 (12.5)

 
  1. aChi-square of Fisher’s exact test as appropriate. A: standard dressing; ASA: American Society of Anesthesiologists score; B: Aquacel Ag Hydrofiber dressing.